Immuneering Corporation (IMRX) vs KORU Medical Systems, Inc. (KRMD)

A side-by-side comparison of Immuneering Corporation and KORU Medical Systems, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — IMRX vs KRMD

growth of $100 · dividends reinvested · last 5y
IMRX -77.0% (-25.5%/yr)KRMD -14.5% (-3.1%/yr)KRMD compounded faster over this window
050100150200Start $10020222023202420252026$23$86
IMRX KRMD

IMRX vs KRMD: by the numbers

  • •IMRX is the larger company ($139M vs $138M market cap).
  • •Both run net losses; IMRX's is the smaller (0.00% vs -4.03% net margin).

Metrics side by side

Valuation

MetricIMRXKRMD
P/S ratioN/A3.05
P/B ratio0.737.63
FCF yieldN/A0.19%

Profitability

MetricIMRXKRMD
Gross margin0.00%61.99%
Operating margin0.00%-3.66%
Net margin0.00%-4.03%
ROE-30.03%-10.08%
ROIC-32.73%-7.95%

Growth (annualized)

MetricIMRXKRMD
Revenue CAGR (5Y)N/A16.42%
Total return CAGR (5Y)-32.77%1.60%

Frequently asked

How have IMRX and KRMD total returns compared?
Over the past 5 years, IMRX delivered -32.77% and KRMD delivered 1.60% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.